HMS Holdings Corp.
I can’t imagine that being atop a list for the worst performing stocks of a quarter is a good thing for any company. It signals operational issues, lost confidence among shareholders, and a total lack of execution. However, looking back on history, most companies experience such a quarter at least once. With that being said I am looking at the top losers of Q3, and will determine if any more »
We have identified five stocks that had absolutely horrible days last week. Assuming the funds we track have not changed their holdings since the end of June, there were key funds that lost big money on these price drops. The first company on our list is HMS Holdings (NASDAQ: HMSY).
The company was down over 23% on Friday, October 26th—around $6.30—after missing quarterly estimates and offering lower more »
By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ
The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.